Nicox Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume656 shs
Market Capitalization$170.70 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NICXF News and Ratings via Email

Sign-up to receive the latest news and ratings for Nicox and its competitors with MarketBeat's FREE daily newsletter.

Nicox logo

About Nicox

Nicox S.A., an ophthalmology company, develops solutions to maintain ocular health in France and internationally. It offers VYZULTA, a latanoprostene bunod ophthalmic solution for open angle glaucoma or ocular hypertension; ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis; and NCX 4280, an ophthalmic solution that targets morning eye congestion. The company also develops NCX 470, a nitric oxide (NO)-donating candidate that is in Phase II clinical trial for the lowering of intraocular pressure in patients with open angle glaucoma or ocular hypertension; and NCX 4251, a patented formulation of fluticasone propionate, which is in Phase II clinical trial for patients with acute exacerbations of blepharitis. Its research product pipeline includes NO-donating phosphodiesterase-5 inhibitors. The company has collaborations with Bausch + Lomb and Ironwood Pharmaceuticals, Inc. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.36 out of 5 stars

Medical Sector

1836th out of 2,105 stocks

Private Households Industry

357th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 1.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Nicox (OTCMKTS:NICXF) Frequently Asked Questions

What stocks does MarketBeat like better than Nicox?

Wall Street analysts have given Nicox a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nicox wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Nicox's stock been impacted by COVID-19?

Nicox's stock was trading at $4.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NICXF shares have increased by 17.2% and is now trading at $5.10.
View which stocks have been most impacted by COVID-19

Who are Nicox's key executives?

Nicox's management team includes the following people:
  • Mr. Michele Garufi, Co-Founder, Chairman & CEO (Age 67, Pay $611.35k)
  • Ms. Sandrine Gestin, VP of Fin. (Age 54)
  • Ms. Emmanuelle Pierry, Gen. Counsel & Head of Legal (Age 52)
  • Dr. Gavin Spencer, Exec. VP, Chief Bus. Officer & Head of Corp. Devel. (Age 51)
  • Dr. Ramesh Krishnamoorthy, Sr. Director and Head of Late Stage CMC & Quality Control
  • Dr. Jose Boyer, Interim Head of R&D
  • Dr. Ennio Ongini Ph.D., Consultant

Who are some of Nicox's key competitors?

What is Nicox's stock symbol?

Nicox trades on the OTCMKTS under the ticker symbol "NICXF."

How do I buy shares of Nicox?

Shares of NICXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nicox's stock price today?

One share of NICXF stock can currently be purchased for approximately $5.10.

How much money does Nicox make?

Nicox has a market capitalization of $170.70 million and generates $9.25 million in revenue each year.

How many employees does Nicox have?

Nicox employs 34 workers across the globe.

What is Nicox's official website?

The official website for Nicox is www.nicox.com.

Where are Nicox's headquarters?

Nicox is headquartered at Drakkar 2 - Batiment D 2405 route des Dolines - CS 10313 Sophia Antipolis Cedex, Valbonne I0, 06560.

How can I contact Nicox?

Nicox's mailing address is Drakkar 2 - Batiment D 2405 route des Dolines - CS 10313 Sophia Antipolis Cedex, Valbonne I0, 06560. The company can be reached via phone at 33-4-97-24-53-00.

This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.